What is Entrada Therapeutics, Inc. Common Stock's Market Cap?

Entrada Therapeutics, Inc. Common Stock's Market Cap is $276.8M, based on as-reported figures from SEC (XBRL) filings.

What is Entrada Therapeutics, Inc. Common Stock's Enterprise Value?

Entrada Therapeutics, Inc. Common Stock's Enterprise Value is $177.6M, based on as-reported figures from SEC (XBRL) filings.

What is Entrada Therapeutics, Inc. Common Stock's Price / Sales?

Entrada Therapeutics, Inc. Common Stock's Price / Sales is 59.1×, based on as-reported figures from SEC (XBRL) filings.

What is Entrada Therapeutics, Inc. Common Stock's EV / Revenue?

Entrada Therapeutics, Inc. Common Stock's EV / Revenue is 37.9×, based on as-reported figures from SEC (XBRL) filings.

What is Entrada Therapeutics, Inc. Common Stock's EV / EBITDA?

Entrada Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Entrada Therapeutics, Inc. Common Stock's Revenue (TTM)?

Entrada Therapeutics, Inc. Common Stock's Revenue (TTM) is $4.7M, based on as-reported figures from SEC (XBRL) filings.

What is Entrada Therapeutics, Inc. Common Stock's Net Income (TTM)?

Entrada Therapeutics, Inc. Common Stock's Net Income (TTM) is -$165.8M, based on as-reported figures from SEC (XBRL) filings.

What is Entrada Therapeutics, Inc. Common Stock's EBITDA?

Entrada Therapeutics, Inc. Common Stock's EBITDA is -$172.8M, based on as-reported figures from SEC (XBRL) filings.

What is Entrada Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Entrada Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -4.26, based on as-reported figures from SEC (XBRL) filings.

What is Entrada Therapeutics, Inc. Common Stock's EBITDA Margin?

Entrada Therapeutics, Inc. Common Stock's EBITDA Margin is -3686.8%, based on as-reported figures from SEC (XBRL) filings.

Entrada Therapeutics, Inc. Common Stock (TRDA) Financial Statements

Entrada Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00MTSMC25

XNAS · usd

7.11▼ 0.41 (-5.45%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close7.52

Day's Range7.02 – 7.55

52-Week Range5.02 – 16.45

Volume381.8K

Avg Volume323.5K

Share Statistics

Shares Outstanding

Employees152

ExchangeXNAS

Listed2021-10-29

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Entrada Therapeutics, Inc. Common Stock (TRDA)

What is Entrada Therapeutics, Inc. Common Stock's Market Cap?: Entrada Therapeutics, Inc. Common Stock's Market Cap is $276.8M, based on as-reported figures from SEC (XBRL) filings.
What is Entrada Therapeutics, Inc. Common Stock's Enterprise Value?: Entrada Therapeutics, Inc. Common Stock's Enterprise Value is $177.6M, based on as-reported figures from SEC (XBRL) filings.
What is Entrada Therapeutics, Inc. Common Stock's Price / Sales?: Entrada Therapeutics, Inc. Common Stock's Price / Sales is 59.1×, based on as-reported figures from SEC (XBRL) filings.
What is Entrada Therapeutics, Inc. Common Stock's EV / Revenue?: Entrada Therapeutics, Inc. Common Stock's EV / Revenue is 37.9×, based on as-reported figures from SEC (XBRL) filings.
What is Entrada Therapeutics, Inc. Common Stock's EV / EBITDA?: Entrada Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Entrada Therapeutics, Inc. Common Stock's Revenue (TTM)?: Entrada Therapeutics, Inc. Common Stock's Revenue (TTM) is $4.7M, based on as-reported figures from SEC (XBRL) filings.
What is Entrada Therapeutics, Inc. Common Stock's Net Income (TTM)?: Entrada Therapeutics, Inc. Common Stock's Net Income (TTM) is -$165.8M, based on as-reported figures from SEC (XBRL) filings.
What is Entrada Therapeutics, Inc. Common Stock's EBITDA?: Entrada Therapeutics, Inc. Common Stock's EBITDA is -$172.8M, based on as-reported figures from SEC (XBRL) filings.
What is Entrada Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Entrada Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -4.26, based on as-reported figures from SEC (XBRL) filings.
What is Entrada Therapeutics, Inc. Common Stock's EBITDA Margin?: Entrada Therapeutics, Inc. Common Stock's EBITDA Margin is -3686.8%, based on as-reported figures from SEC (XBRL) filings.